Data Collection Protocol for Patients With Von Hippel Lindau Disease

NCT05955014•M.D. Anderson Cancer Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Von Hippel Lindau Disease

Locations

United States

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States

Key Dates

Start Date

August 24, 2023

Primary Completion Date

December 31, 2026

Completion Date

December 31, 2026

Last Updated

November 20, 2025

Related Studies

TERMINATED

Von Hippel-Lindau Disease Genetic Epidemiology Study

NCT00001803

Von Hippel Lindau DiseaseKidney Neoplasms

View study

Contacts

Eric Jonasch, MD

CONTACT

(713) 563-7232 ejonasch@mdanderson.org

Sponsors

Lead Sponsor

M.D. Anderson Cancer Center

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions